Literature DB >> 16446103

Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy.

S Anand Trip1, Patricio G Schlottmann, Stephen J Jones, Wai-Yung Li, David F Garway-Heath, Alan J Thompson, Gordon T Plant, David H Miller.   

Abstract

Magnetic resonance imaging (MRI) measures of brain atrophy are often considered to be a marker of axonal loss in multiple sclerosis (MS) but evidence is limited. Optic neuritis is a common manifestation of MS and results in optic nerve atrophy. Retinal nerve fibre layer (RNFL) imaging is a non-invasive way of detecting axonal loss following optic neuritis. We hypothesise that if the optic nerve atrophy that develops following optic neuritis is contributed to by axonal loss, it will correlate with thinning of the RNFL. Twenty-five patients were studied at least 1 year after a single unilateral attack of optic neuritis without recurrence, with a selection bias towards incomplete recovery. They had MR quantification of optic nerve cross-sectional area and optic nerve lesion length, as well as optical coherence tomography (OCT) measurement of mean RNFL thickness and macular volume, quantitative visual testing, and visual evoked potentials (VEPs). Fifteen controls were also studied. Significant optic nerve atrophy (mean decrease 30% versus controls), RNFL thinning (mean decrease 33% versus controls), and macular volume loss occurred in patients' affected eyes when compared with patients' unaffected eyes and healthy controls. The optic nerve atrophy was correlated with the RNFL thinning, macular volume loss, visual acuity, visual field mean deviation, and whole field VEP amplitude but not latency. These findings suggest that axonal loss contributes to optic nerve atrophy following a single attack of optic neuritis. By inference, axonal loss due to other post-inflammatory brain lesions is likely to contribute to the global MRI measure of brain atrophy in multiple sclerosis.

Entities:  

Mesh:

Year:  2006        PMID: 16446103     DOI: 10.1016/j.neuroimage.2005.11.051

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  50 in total

1.  Optical coherence tomography as a potential readout in clinical trials.

Authors:  Benjamin M Greenberg; Elliot Frohman
Journal:  Ther Adv Neurol Disord       Date:  2010-05       Impact factor: 6.570

2.  Comparison of retinal nerve fiber layer measured by time domain and spectral domain optical coherence tomography in optic neuritis.

Authors:  G Rebolleda; A García-García; H R Won Kim; F J Muñoz-Negrete
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

3.  Diffusion tensor imaging of the optic tracts in multiple sclerosis: association with retinal thinning and visual disability.

Authors:  Hormuzdiyar H Dasenbrock; Seth A Smith; Arzu Ozturk; Sheena K Farrell; Peter A Calabresi; Daniel S Reich
Journal:  J Neuroimaging       Date:  2011-04       Impact factor: 2.486

Review 4.  Neurophysiological markers.

Authors:  Letizia Leocani; Giancarlo Comi
Journal:  Neurol Sci       Date:  2008-09       Impact factor: 3.307

Review 5.  Assessing structure and function of the afferent visual pathway in multiple sclerosis and associated optic neuritis.

Authors:  Madhan Kolappan; Andrew P D Henderson; Thomas M Jenkins; Claudia A M Wheeler-Kingshott; Gordon T Plant; Alan J Thompson; David H Miller
Journal:  J Neurol       Date:  2009-03-18       Impact factor: 4.849

6.  Longitudinal evidence for anterograde trans-synaptic degeneration after optic neuritis.

Authors:  Carmen Tur; Olivia Goodkin; Daniel R Altmann; Thomas M Jenkins; Katherine Miszkiel; Alessia Mirigliani; Camilla Fini; Claudia A M Gandini Wheeler-Kingshott; Alan J Thompson; Olga Ciccarelli; Ahmed T Toosy
Journal:  Brain       Date:  2016-02-17       Impact factor: 13.501

7.  Functional loss in the magnocellular and parvocellular pathways in patients with optic neuritis.

Authors:  Dingcai Cao; Andrew J Zele; Joel Pokorny; David Y Lee; Leonard V Messner; Christopher Diehl; Susan Ksiazek
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-11-17       Impact factor: 4.799

8.  Optical coherence tomography is less sensitive than visual evoked potentials in optic neuritis.

Authors:  R T Naismith; N T Tutlam; J Xu; J B Shepherd; E C Klawiter; S-K Song; A H Cross
Journal:  Neurology       Date:  2009-07-07       Impact factor: 9.910

9.  Optic Nerve Measurement on MRI in the Pediatric Population: Normative Values and Correlations.

Authors:  C E Al-Haddad; M G Sebaaly; R N Tutunji; C J Mehanna; S R Saaybi; A M Khamis; R G Hourani
Journal:  AJNR Am J Neuroradiol       Date:  2017-12-07       Impact factor: 3.825

10.  Optical coherence tomography in multiple sclerosis: thickness of the retinal nerve fiber layer as a potential measure of axonal loss and brain atrophy.

Authors:  Malgorzata Siger; Krzysztof Dziegielewski; Lukasz Jasek; Marek Bieniek; Agnieszka Nicpan; Jerzy Nawrocki; Krzysztof Selmaj
Journal:  J Neurol       Date:  2008-09-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.